臨床検査63巻12号

2019年12月発行

記事購入ページに移動

今月の特集2 高血圧の臨床—生理検査を中心に

睡眠時無呼吸症候群と高血圧

著者： 得能智武¹

所属機関： ¹九州大学病院別府病院内科

ページ範囲：P.1465 - P.1469

Point

●睡眠時無呼吸症候群（SAS）は，治療抵抗性高血圧の原因であることが多く，高血圧症を治療する場合，鑑別の1つとして考える必要がある．

●睡眠中に無呼吸が起こると低酸素から交感神経活性化を介して夜間高血圧，早朝高血圧をきたすが，長期罹患重症例は，昼間の高血圧の原因にもなる．

●重症例においては，持続陽圧呼吸療法（CPAP）などによる積極的な加療により，血圧コントロールが改善する症例も認める．

参考文献

1）Carnethon MR, Johnson DA：Sleep and Resistant Hypertension. Curr Hypertens Rep　21：34，2019

2）Johnson DA, Thomas SJ, Abdalla M, et al：Association Between Sleep Apnea and Blood Pressure Control Among Blacks. Circulation　139：1275-1284，2019

3）He J, Kryger MH, Zorick FJ, et al：Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest　94：9-14，1988

4）Nieto FJ, Young TB, Lind BK, et al：Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA　283：1829-1836，2000

5）Irvin MR, Booth JN 3rd, Shimbo D, et al：Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality. J Am Soc Hypertens　8：405-413，2014

6）Muntner P, Davis BR, Cushman WC, et al：Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension　64：1012-1021，2014

7）Dudenbostel T, Siddiqui M, Oparil S, et al：Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment Failure. Hypertension　67：1085-1092，2016

8）Logan AG, Perlikowski SM, Mente A, et al：High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens　19：2271-2277，2001

9）Floras JS：Hypertension and Sleep Apnea. Can J Cardiol　31：889-897，2015

10）Sapiña-Beltrán E, Santamaria-Martos F, Benítez I, et al：Normotensive patients with obstructive sleep apnoea: changes in 24-h ambulatory blood pressure monitoring with continuous positive airway pressure treatment. J Hypertens　37：720-727，2019

11）Yokoe T, Minoguchi K, Matsuo H, et al：Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation　107：1129-1134, 2003

12）Tam W, Ng SS, To KW, et al：The interaction between hypertension and obstructive sleep apnea on subjective daytime sleepiness. J Clin Hypertens (Greenwich)　21：390-396，2019

13）福原俊一，竹上未紗，鈴鴨よしみ，他：日本語版the Epworth Sleepiness Scale（JESS）．日呼吸会誌　44：896-898，2006

14）Tsai WH, Remmers JE, Brant R, et al：A decision rule for diagnostic testing in obstructive sleep apnea. Am J Respir Crit Care Med　167：1427-1432，2003

15）Berry RB, Budhiraja R, Gottlieb DJ, et al：Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med　8：597-619，2012

16）Sawatari H, Chishaki A, Nishizaka M, et al：Cumulative Hypoxemia During Sleep Predicts Vascular Endothelial Dysfunction in Patients With Sleep-Disordered Breathing. Am J Hypertens　29：458-463，2016

17）Martínez-García MA, Capote F, Campos-Rodríguez F, et al：Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA　310：2407-2415，2013

18）Yamamoto U, Nishizaka M, Tsuda H, et al：Crossover comparison between CPAP and mandibular advancement device with adherence monitor about the effects on endothelial function, blood pressure and symptoms in patients with obstructive sleep apnea. Heart Vessels　34：1692-1702，2019

19）Certal VF, Zaghi S, Riaz M, et al：Hypoglossal nerve stimulation in the treatment of obstructive sleep apnea: A systematic review and meta-analysis. Laryngoscope　125：1254-1264，2015